arrow_back Trending Legislation
Share share

Tracking Xylazine Sources: New International Drug Control Reporting Requirements.

This law aims to enhance public safety by improving the monitoring of dangerous substances in international trade. It requires the US government to identify countries that are significant sources of xylazine, commonly known as "Tranq," in the annual International Narcotics Control Strategy Report. Better tracking of this substance, often mixed with fentanyl, is intended to help limit its availability and reduce fatal overdoses in communities.
Key points
The US government must now track and report which countries are the primary suppliers of xylazine (Tranq) globally.
Xylazine, a dangerous animal tranquilizer, is increasingly mixed with illegal drugs, raising health and safety risks for citizens.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
STOP TRANQ Act
Print number: S 4025
Sponsor: Sen. Cruz, Ted [R-TX]
Process start date: 2024-03-21
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Tracking Xylazine Sources: New International Drug Control Reporting Requirements.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 4025.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-03-21.

What are the main provisions?

Key points include:

  • The US government must now track and report which countries are the primary suppliers of xylazine (Tranq) globally.
  • Xylazine, a dangerous animal tranquilizer, is increasingly mixed with illegal drugs, raising health and safety risks for citizens.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cruz, Ted [R-TX].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of S 4025

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Security Health